6O8U
Crystal structure of IRAK4 in complex with compound 23
Summary for 6O8U
Entry DOI | 10.2210/pdb6o8u/pdb |
Descriptor | Interleukin-1 receptor-associated kinase 4, N-[2,2-dimethyl-6-(morpholin-4-yl)-2,3-dihydro-1-benzofuran-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide, SULFATE ION, ... (5 entities in total) |
Functional Keywords | kinase, inhibitor, inflammation, lupus, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 4 |
Total formula weight | 139032.26 |
Authors | Kiefer, J.R.,Yu, C.,Drobnick, J.,Bryan, M.C.,Lupardus, P.J. (deposition date: 2019-03-12, release date: 2019-05-22, Last modification date: 2019-07-24) |
Primary citation | Bryan, M.C.,Drobnick, J.,Gobbi, A.,Kolesnikov, A.,Chen, Y.,Rajapaksa, N.,Ndubaku, C.,Feng, J.,Chang, W.,Francis, R.,Yu, C.,Choo, E.F.,DeMent, K.,Ran, Y.,An, L.,Emson, C.,Huang, Z.,Sujatha-Bhaskar, S.,Brightbill, H.,DiPasquale, A.,Maher, J.,Wai, J.,McKenzie, B.S.,Lupardus, P.J.,Zarrin, A.A.,Kiefer, J.R. Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors. J.Med.Chem., 62:6223-6240, 2019 Cited by PubMed: 31082230DOI: 10.1021/acs.jmedchem.9b00439 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.8 Å) |
Structure validation
Download full validation report